Licensing to Solve the Innovation Gap
The 2012 Spring Meeting is a highly targeted event that will focus primarily on the breaking developments and hot topics facing IP, licensing and business development professionals in the Life Sciences industry.
Listen to an Interview with Keynote David Meeker, President & CEO of Genzyme
Click below to listen to this interview by Meeting Chair Mark Nawacki, where Dr. Meeker offers an inside look at how his company has leveraged strategic licensing and provides a preview of what we can expect at his talk in Boston next month.
If you prefer, you may download the interview audio file by clicking here.
Can't Attend the Spring Meeting in Person? Attend Virtually!
We're excited to announce our new virtual meeting option for those who can't join us in Boston. Click here for details.
ENGAGE WITH INDUSTRY THOUGHT LEADERS DURING THESE FEATURED PLENARY SESSIONS:
Licensing to Solve the Innovation Gap
Speakers:
Daniel Behr, Senior Vice President, Access BridgeGap Ventures
Jeff Elton, Managing Director, Accenture
Robert S. Langer, David H. Koch Institute Professor, MIT
Keynote
Licensing as a Source of Innovation
Speaker:
David Meeker, President & CEO, Genzyme
Tales from the Trenches – a Spotlight on Deals in the News
Speakers:
Ariel D. Jasie, Senior Director, Business Development, Celgene Corporation
Nagesh Mahanthappa, VP Corporate Development & Operations, Avila Therapeutics
Michal Preminger, Executive Director of Office of Technology Development, Harvard Medical School Office
*Please note: David Meeker is replacing George Scangos.